The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?
Dreger
P
P
Ritgen
M
M
Böttcher
S
S
Schmitz
N
N
Kneba
M
M
D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000628:therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods